Role of Mesohepatectomy for Pediatric Centrally Located Liver Tumors

Shajini Nirmalan1, Senthilnathan Ramaswamy1, Vivek Shanmugam1

  • 1Department of Paediatric Surgery, Institute of Child Health, Madras Medical College, Chennai, Tamil Nadu, India.

Abstract

Insights

Mesohepatectomy (MH), a central liver resection, effectively treats pediatric liver tumors while preserving liver tissue. This study shows MH is feasible for specific tumors, offering outcomes comparable to extensive resections.

Area of Science:

  • Pediatric Surgery
  • Surgical Oncology
  • Hepatobiliary Surgery

Background:

  • Mesohepatectomy (MH), also known as central hepatectomy (CH), is a surgical approach for centrally located pediatric liver tumors.
  • This liver resection technique aims to preserve liver parenchyma by avoiding extended resections.

Purpose of the Study:

  • To analyze the experience and outcomes of mesohepatectomy (MH) in pediatric liver tumor cases.
  • Evaluate the feasibility and effectiveness of central hepatectomy (CH) in a pediatric cohort.

Main Methods:

  • Retrospective analysis of patients who underwent MH between January 2015 and June 2023.
  • Collected data included demographics, preoperative treatment, perioperative management, and postoperative outcomes.

Main Results:

  • Five pediatric patients underwent CH for liver tumors (four hepatoblastoma, one mesenchymal hamartoma).
  • All patients achieved negative surgical margins; one recurrence led to metastasis and death.
  • Complications included one intraoperative bile duct injury and one postoperative bile collection.

Conclusions:

  • Mesohepatectomy (MH) with clear margins is a viable option for selected pediatric liver tumors involving segments IV, V, and VIII.
  • Outcomes of MH are comparable to those of extended hepatic resections in this patient subset.

Related Concept Videos